Dynavax Technologies Corp (DVAX)
11.79
+0.44
(+3.88%)
USD |
NASDAQ |
Apr 19, 16:00
11.77
-0.02
(-0.17%)
After-Hours: 17:47
Dynavax Technologies Gross Profit (Quarterly): 46.91M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 46.91M |
September 30, 2023 | 56.28M |
June 30, 2023 | 46.71M |
March 31, 2023 | 32.21M |
December 31, 2022 | 107.00M |
September 30, 2022 | 106.40M |
June 30, 2022 | 173.10M |
March 31, 2022 | 74.03M |
December 31, 2021 | 121.06M |
September 30, 2021 | 48.18M |
June 30, 2021 | 37.92M |
March 31, 2021 | 58.71M |
December 31, 2020 | 15.49M |
September 30, 2020 | 9.383M |
June 30, 2020 | 1.499M |
March 31, 2020 | 6.267M |
December 31, 2019 | 5.84M |
September 30, 2019 | 4.427M |
June 30, 2019 | 3.863M |
March 31, 2019 | 1.70M |
December 31, 2018 | 1.369M |
September 30, 2018 | -6.289M |
June 30, 2018 | -6.221M |
March 31, 2018 | -2.457M |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 1.174M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
1.499M
Minimum
Jun 2020
173.10M
Maximum
Jun 2022
50.28M
Average
46.71M
Median
Jun 2023
Gross Profit (Quarterly) Benchmarks
Supernus Pharmaceuticals Inc | 144.69M |
Ligand Pharmaceuticals Inc | 26.46M |
Pacira BioSciences Inc | 133.55M |
Esperion Therapeutics Inc | 20.80M |
PetIQ Inc | 43.99M |